Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Amylyx Pharmaceuticals
AMLX
$2.41B
| $17.5M | ﹤0.01% |
813,325
+584,419
| +255% | +$15.8M |
|
1977
Globus Medical
GMED
$11.5B
| $17.5M | ﹤0.01% |
294,532
-834,133
| -74% | -$47.5M |
|
1978
Alexandria Real Estate Equities
ARE
$8.28B
| $17.5M | ﹤0.01% |
154,365
+58,787
| +62% | +$7M |
|
|
IMGN
1979
DELISTED
Immunogen Inc
IMGN
| $17.5M | ﹤0.01% |
928,240
-46,818
| -5% | -$553K |
|
1980
iShares Select Dividend ETF
DVY
$24.1B
| $17.5M | ﹤0.01% |
154,315
+105,893
| +219% | +$12.1M |
|
1981
Urban Outfitters
URBN
$6.66B
| $17.4M | ﹤0.01% |
526,594
+191,539
| +57% | +$5.59M |
|
1982
Hims & Hers Health
HIMS
$6.57B
| $17.4M | ﹤0.01% |
1,855,170
-15,106
| -0.8% | -$150K |
|
1983
PUT
HSBC
HSBC
$357B
| $17.4M | ﹤0.01% |
440,100
-179,700
| -29% | -$6.71M |
|
1984
PUT
Vornado Realty Trust
VNO
$7.28B
| $17.4M | ﹤0.01% |
960,600
+684,700
| +248% | +$10.1M |
|
|
MRTX
1985
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $17.4M | ﹤0.01% |
481,818
+391,174
| +432% | +$16.1M |
|
1986
Azenta
AZTA
$1.46B
| $17.4M | ﹤0.01% |
372,921
+169,334
| +83% | +$7.41M |
|
1987
PUT
ChargePoint
CHPT
$160M
| $17.4M | ﹤0.01% |
98,965
+9,835
| +11% | +$1.72M |
|
1988
Medpace
MEDP
$16.1B
| $17.4M | ﹤0.01% |
72,415
+70,271
| +3,278% | +$14.6M |
|
1989
CALL
EPAM Systems
EPAM
$5.18B
| $17.4M | ﹤0.01% |
77,300
+15,300
| +25% | +$3.85M |
|
1990
NNN REIT
NNN
$8.83B
| $17.3M | ﹤0.01% |
405,345
+344,196
| +563% | +$14.8M |
|
1991
CALL
argenx
ARGX
$53.3B
| $17.3M | ﹤0.01% |
44,500
+6,300
| +16% | +$2.48M |
|
1992
PUT
Southern Company
SO
$107B
| $17.3M | ﹤0.01% |
246,800
-559,700
| -69% | -$40.1M |
|
1993
Bausch Health
BHC
$2.43B
| $17.3M | ﹤0.01% |
2,166,263
+1,666,151
| +333% | +$12.3M |
|
|
K
1994
DELISTED
Kellanova
K
| $17.3M | ﹤0.01% |
273,800
+252,581
| +1,190% | +$16.1M |
|
1995
CALL
Centene
CNC
$33.3B
| $17.3M | ﹤0.01% |
256,300
-244,600
| -49% | -$16.3M |
|
1996
CALL
RingCentral
RNG
$5.39B
| $17.2M | ﹤0.01% |
526,900
-110,200
| -17% | -$3.39M |
|
1997
Fulgent Genetics
FLGT
$511M
| $17.2M | ﹤0.01% |
464,422
+166,247
| +56% | +$5.79M |
|
1998
PUT
Raymond James Financial
RJF
$34.8B
| $17.2M | ﹤0.01% |
165,700
+135,700
| +452% | +$12.6M |
|
1999
CALL
Western Digital
WDC
$175B
| $17.2M | ﹤0.01% |
598,922
-919,617
| -61% | -$25.6M |
|
2000
CALL
Consolidated Edison
ED
$40.2B
| $17.1M | ﹤0.01% |
189,500
-146,000
| -44% | -$14M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.